Cite INHERENT:
Kountouris P, Stephanou C, Archer N, Bonifazi F, Giannuzzi V, Kuo KHM, Maggio A, Makani J, Mañú-Pereira MDM, Michailidou K, Nkya S, Nnodu OE, Trompeter S, Tshilolo L, Wonkam A, Zilfalil BA, Inusa BPD, Kleanthous M; on behalf of the International Hemoglobinopathy Research Network (INHERENT). The International Hemoglobinopathy Research Network (INHERENT): An international initiative to study the role of genetic modifiers in hemoglobinopathies. Am J Hematol. 2021 Nov 1;96(11):E416-E420. doi: 10.1002/ajh.26323. Epub 2021 Aug 30. PMID: 34406671
INHERENT publications
- Evangelidis P, Venou TM, Fani B, Vlachaki E, Gavriilaki E; on behalf of the International Hemoglobinopathy Research Network (INHERENT). Endocrinopathies in Hemoglobinopathies: What Is the Role of Iron? Int J Mol Sci. 2023 Nov 13;24(22):16263. doi: 10.3390/ijms242216263. PMID: 38003451
- Traeger-Synodinos J, Vrettou C, Sofocleous C, Zurlo M, Finotti A, Gambari R; International Hemoglobinopathy Research Network (INHERENT). Impact of α-Globin Gene Expression and α-Globin Modifiers on the Phenotype of β-Thalassemia and Other Hemoglobinopathies: Implications for Patient Management. Int J Mol Sci. 2024 Mar 17;25(6):3400. doi: 10.3390/ijms25063400. PMID: 38542374
- Gambari R, Waziri AD, Goonasekera H, Peprah E. Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications. Int J Mol Sci. 2024 Apr 12;25(8):4263. doi: 10.3390/ijms25084263. PMID: 38673849.